Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Lung cancer, non-small cell
Stage/Subtype:  stage I non-small cell lung cancer
Country:  U.S.A.
Trial Type:  Treatment
Results 1-25 of 31 for your search:
Start Over
Comparison of Different Types of Surgery in Treating Patients with Stage IA Non-Small Cell Lung Cancer
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: CALGB 140503, NCI-2009-00447, CDR0000555324, ECOG-40503, NCT00499330
Erlotinib Hydrochloride in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: A081105, NCI-2014-01508, CALGB A081105, NCT02193282
Crizotinib in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: E4512, NCI-2014-01507, NCT02201992
Indocyanine Green Solution and Near-Infrared Fluorescence Imaging in Lymph Node Mapping in Patients with Stage I-II Non-small Cell Lung Cancer Undergoing Surgery
Phase: Phase II, Phase I
Type: Diagnostic, Treatment
Age: 18 and over
Trial IDs: 05-219, NCI-2012-00260, NCT00264602
A Phase I/II Trial of Stereotactic Body Radiation Therapy (SBRT)
Phase: Phase II, Phase I
Type: Treatment
Age: Over 18
Trial IDs: 06-0691 / 201012832, NCI-2011-00543, 06-0691, 201012832, NCT00591838
Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: M11VOL, NCI-2015-00776, NCT01543672
Vaccine Therapy in Treating Patients With Stage I-III Non-Small Cell Lung Cancer
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: UPCI 11-094, NCI-2013-00081, NCT01720836
Vaccine Therapy and Iscomatrix with or without Cyclophosphamide and Celecoxib in Treating Patients with Thoracic Malignancies or Tumors That Have Spread to the Chest Cavity
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 14-C-0053, NCI-2014-02465, 140053, P131392, NCT02054104
Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: 2012-0347, NCI-2012-01249, R01CA026582, NCT01636934
Afatinib Dimaleate in Treating Patients with Stage I-III Non-small Cell Lung Cancer That Was Removed by Surgery
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 12-504, NCI-2013-01108, NCT01746251
Combination Chemotherapy and Ipilimumab before Surgery in Treating Patients with Stage IB-III Non-small Cell Lung Cancer That Can Be Removed by Surgery
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: Pro00038093, NCI-2013-00721, CA184-203, TOP 1201, NCT01820754
Nivolumab in Treating Patients with Stage I-IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery
Phase: Phase II
Type: Treatment
Age: 18 to 95
Trial IDs: J1414, NCI-2015-00243, CIR00010768, NA_00092076, NA_00092076 / CIR00010768, NA_00092076/ J1414, NCT02259621
Afatinib Dimaleate in Treating Patients with Stage IA-IIIA Non-small Cell Lung Cancer before Surgery
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2013-0305, NCI-2015-00357, NCT02271906
Metformin Hydrochloride in Treating Patients with Stage Ib/IIa Non-small Cell Lung Cancer Undergoing Stereotactic Body Radiation Therapy
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2014-0255, NCI-2015-00287, NCT02285855
Vaccine Therapy in Treating Patients with Non-small Cell Lung Cancer
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 08-004, NCI-2014-01874, UPCI 08-004, NCT00793208
Stereotactic Body Radiation Therapy and Ablation Therapy in Treating Patients With Non-Small Cell Lung Cancer or Lung Metastases
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: INST 1206, NCI-2012-01181, 12-242, NCT01746810
Heated Cisplatin following Surgery in Treating Younger Patients with Primary or Metastatic Pleural Malignancies
Phase: Phase I
Type: Treatment
Age: 3 to 21
Trial IDs: 2012-0657, NCI-2014-01101, NCI-2014-00510, NCT01998529
Cisplatin, Docetaxel, and Nintedanib before Surgery in Treating Patients with Previously Untreated Stage IB-IIIA Non-small Cell Lung Cancer
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 2013-0844, NCI-2014-02091, NCT02225405
Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Non-Small Cell Lung Cancer And Bronchial Disease
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: Not specified
Trial IDs: OSU 07115, NCI-2011-03195, 2008C0055, OSU-2008C0055, NCT00754910
Biomarker Modulation in Patients With Squamous Cell Carcinoma of the Head and Neck or Stage I-IIIA Non-Small Cell Lung Cancer Receiving Erlotinib Hydrochloride With or Without Dasatinib
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 07-124, NCI-2011-02477, NCT00779389
High Dose Rate Brachytherapy in Treating Patients with Endometrial, Cervical, Lung, Breast, or Prostate Cancer
Phase: No phase specified
Type: Natural history/Epidemiology, Treatment
Age: 18 to 90
Trial IDs: 09-C-0100, NCI-2013-01448, 090100, P08407, NCT00924027
Vaccine Therapy and Celecoxib in Treating Patients with Lung Cancer, Esophageal Cancer, Thymic Cancers, Thoracic Sarcomas, or Malignant Pleural Mesotheliomas Undergoing Surgery
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 11-C-0041, NCI-2013-01472, 110041, P09574, NCT01258868
Evaluating an Anchored Transponder in Lung Cancer Patients Receiving Radiation Therapy
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: CMT - 01-10, NCI-2012-00203, NCT01396551
Start Over